ALBT
Avalon GlobocareยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ALBT Profile
Avalon Globocare Corp
A leading global developer of innovative cell-based technologies and therapeutics
Biological Technology
07/28/2014
11/05/2018
NASDAQ Stock Exchange
5
12-31
Common stock
4400 Route 9 South, Suite 3100, Freehold, New Jersey 07728
--
Avalon Globocare Corp was incorporated under the laws of the State of Delaware on July 28, 2014. Avalon GloboCare Corpare is committed to integrating and managing global healthcare services and resources, as well as empowering high-impact biomedical innovations and technologies to accelerate their clinical application. The company's "technology + services" ecosystem covers the fields of regenerative medicine, cellular immunotherapy, exosomal technology and rehabilitation medicine through two main platforms, "Avalon Cell" and "Avalon Rehab". The company plans to integrate these services through joint ventures and value-added acquisitions in the short term through operating entities (as part of Avalon Rehab) and in the long term through biomedical innovation development as part of Avalon Cell (such as their recent joint venture) exosome separation systems and related products.
